The World Health Organization (WHO) today confirmed a fatal Middle East respiratory syndrome coronavirus (MERS-CoV) case in an Omani man that was reported by the media a week ago and revealed that he had extensive contact with camels.
Construction has begun on a plant in north Florida that will enable the Department of Defense (DoD) to produce its own vaccines and drugs against potential bioterror threats, an effort that appears to duplicate Department of Health and Human Services (HHS) efforts, the Los Angeles Times reported.
South Korea and the United States will establish a surveillance system against biological weapon threats from North Korea, Seoul-based The Chosun Ilbo reported today.
More than half of 70 first responders surveyed did not know that occupants of an entire building need decontamination following an indoor release of Bacillus anthracis, the bacterium that causes anthrax, according to a study in the Journal of Homeland Security and Emergency Management.
Discovery of the first new botulinum toxin in 40 years is coupled with withholding key data for security reasons.
Neither the seasonal trivalent (three-strain) influenza vaccine (TIV) nor a monovalent H3N2 vaccine substantially reduced shedding of variant H3N2 (H3N2v) virus in ferrets, but previous infection with a seasonal H3N2 virus did, according to a study yesterday in the Journal of Virology.
Saudi Arabia has reported three more Middle East Respiratory syndrome coronavirus (MERS-CoV) cases, according to a machine-translated Saudi government statement posted on disease-tracking Web sites.
The US Department of Homeland Security (DHS) is asking for bids on a 24/7 service to provide global data on disease outbreaks and other biologic threats, the agency said in a release this week.
The CDC today announced $75 million in grants to help states and cities respond to infectious disease threats.
A new molecular strategy could diffuse some of the controversy over lab-modified flu viruses.
